Dyee Capital
Asia, Fujian, China, Xiamen'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Dyee Capital is an investment firm.
Investor Profile
Dyee Capital has backed more than 8 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 13% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series D, Seed rounds (top funding stages).
- Majority of deals are located in China.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Series C (50%)
- Series D (13%)
- Seed (13%)
- Series E (13%)
- Series A (13%)
Country Focus
- China (100%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Biopharma
- Medical
- Oncology
- Medical Device
- E-commerce
- Logistics
- Supply Chain Management
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
